EUCTR2019-001285-15-SI进行中（未招募）1 期
Platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention
niversity Medical Centre Ljubljana0 个研究点目标入组 30 人开始时间: 2019年3月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- age 18 to 70 years
- •- comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention
- •- treatment with induced therapeutic hypothermia
- •- no contraindication for dual antiplatelet therapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •- pregnancy
- •- patients without return of spontaneous circulation or patients on ECMO
- •- history of recent P2Y12 use (last 7 days)
- •- history of recent vitamin K antagonist or NOAC use (last 14 days)
- •- active bleeding
- •- history of transient ischemic attack or cerebral vascular insult
- •- strong bleeding tendency (Child C liver cirrhosis, stage IV-V chronic renal disease)
- •- history of allergic reactions to acetylsalicylic acid, heparin or P2Y12 inhibitors
- •- terminal disease or life expectancy less than 1 year
研究者
相似试验
进行中（未招募）
不适用
The effect of administration of blood thinners through a naso-gastrc tube.EUCTR2013-005529-22-DKRigshospitalet50
进行中（未招募）
不适用
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGESubjects who present with an acute coronary syndrome.MedDRA version: 12.0Level: LLTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.0Level: PTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.0Level: LLTClassification code 10006894Term: CABGEUCTR2008-001135-35-CZThe Medicines Company220
进行中（未招募）
不适用
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGEEUCTR2008-001135-35-GBThe Medicines Company220
进行中（未招募）
不适用
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGEEUCTR2008-001135-35-NLThe Medicines Company220
已完成
2 期
Maintenance of platelet inhiBition with cangreloR after dIscontinuation of thienopyriDines in patients undergoing surGEry: The BRIDGE trialplatelet inhibition10011082NL-OMON34815Medicines Company50